Desq Long
Sign in

Company

Akari Therapeutics Plc

AKTX · CIK 0001541157

SEC FORM 4
$7.73

Akari Therapeutics Plc (AKTX)

Acquisition (code M) of 19,333 shares at $0.0004 per share.

Reporting Person Gaslightwala Abizer · Officer Title CEO · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047454 · filed 2026-10-16 · View filing →

SEC FORM 4
$3.09

Akari Therapeutics Plc (AKTX)

Acquisition (code M) of 7,733 shares at $0.0004 per share.

Reporting Person Gaslightwala Abizer · Officer Title CEO · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047454 · filed 2026-10-16 · View filing →

SEC FORM 4
$0.31

Akari Therapeutics Plc (AKTX)

Acquisition (code M) of 773 shares at $0.0004 per share.

Reporting Person Bazemore Robert B · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047455 · filed 2026-10-16 · View filing →

SEC FORM 4
$1.24

Akari Therapeutics Plc (AKTX)

Acquisition (code M) of 3,093 shares at $0.0004 per share.

Reporting Person Bazemore Robert B · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047455 · filed 2026-10-16 · View filing →

SEC FORM 4
$1.55

Akari Therapeutics Plc (AKTX)

Acquisition (code M) of 3,866 shares at $0.0004 per share.

Reporting Person Patel Sandip I · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047456 · filed 2026-10-16 · View filing →

SEC FORM 4
$2.47

Akari Therapeutics Plc (AKTX)

Acquisition (code M) of 6,186 shares at $0.0004 per share.

Reporting Person Patel Sandip I · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047456 · filed 2026-10-16 · View filing →

SEC FORM 4
$17,662.16

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 2,236 shares at $7.899 per share.

Reporting Person Patel Samir Rashmikant · Transaction Code A

Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS

Source: SEC Form 4 · 0001493152-26-047453 · filed 2026-10-16 · View filing →

SEC FORM 4
$36,943.62

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 4,677 shares at $7.899 per share.

Reporting Person Bazemore Robert B · Transaction Code A

Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS

Source: SEC Form 4 · 0001493152-26-047455 · filed 2026-10-16 · View filing →

SEC FORM 4
$34,068.39

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 4,313 shares at $7.899 per share.

Reporting Person Patel Sandip I · Transaction Code A

Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS

Source: SEC Form 4 · 0001493152-26-047456 · filed 2026-10-16 · View filing →

SEC FORM 4
$48,657.84

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 6,160 shares at $7.899 per share.

Reporting Person Huh Hoyoung · Transaction Code A

Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS

Source: SEC Form 4 · 0001493152-26-047457 · filed 2026-10-16 · View filing →

SEC FORM 4
$25,592.76

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 3,240 shares at $7.899 per share.

Reporting Person Prudo-Chlebosz Raymond · Transaction Code A

Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS

Source: SEC Form 4 · 0001493152-26-047458 · filed 2026-10-16 · View filing →

SEC FORM 4
$49,763.70

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 6,300 shares at $7.899 per share.

Reporting Person Patel Samir Rashmikant · Transaction Code A

Traded Aug 18, 2026 · Disclosed Oct 16, 2026FILED +59 DAYS

Source: SEC Form 4 · 0001493152-26-047453 · filed 2026-10-16 · View filing →

SEC FORM 4
$103,476.90

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 13,100 shares at $7.899 per share.

Reporting Person Bazemore Robert B · Transaction Code A

Traded Aug 18, 2026 · Disclosed Oct 16, 2026FILED +59 DAYS

Source: SEC Form 4 · 0001493152-26-047455 · filed 2026-10-16 · View filing →

SEC FORM 4
$95,577.90

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 12,100 shares at $7.899 per share.

Reporting Person Patel Sandip I · Transaction Code A

Traded Aug 18, 2026 · Disclosed Oct 16, 2026FILED +59 DAYS

Source: SEC Form 4 · 0001493152-26-047456 · filed 2026-10-16 · View filing →

SEC FORM 4
$136,249.85

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 17,249 shares at $7.899 per share.

Reporting Person Huh Hoyoung · Transaction Code A

Traded Aug 18, 2026 · Disclosed Oct 16, 2026FILED +59 DAYS

Source: SEC Form 4 · 0001493152-26-047457 · filed 2026-10-16 · View filing →

SEC FORM 4
$71,659.73

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 9,072 shares at $7.899 per share.

Reporting Person Prudo-Chlebosz Raymond · Transaction Code A

Traded Aug 18, 2026 · Disclosed Oct 16, 2026FILED +59 DAYS

Source: SEC Form 4 · 0001493152-26-047458 · filed 2026-10-16 · View filing →

SEC FORM 4
$62,499.60

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 6,430 shares at $9.72 per share.

Reporting Person Gaslightwala Abizer · Officer Title CEO · Transaction Code A

Traded Sep 29, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001493152-26-045366 · filed 2026-10-01 · View filing →

SEC FORM 4
$12,994.56

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 1,728 shares at $7.52 per share.

Reporting Person Farag Kameel D. · Officer Title Interim CFO · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001493152-26-039246 · filed 2026-08-19 · View filing →